Private Harbour Investment Management & Counsel’s AstraZeneca AZN Stock Holding History

Private Harbour Investment Management & Counsel’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-19,372	Closed	-$2.57M	–	51
2022 Q1	$2.57M	Sell	19,372 -2,654	-12%	-$318K	2.15%	16
2021 Q4	$2.57M	Sell	22,026 -216	-1%	-$25.4K	2.05%	16
2021 Q3	$2.67M	Sell	22,242 -72	-0.3%	-$8.38K	2.35%	13
2021 Q2	$2.67M	Buy	+22,314	New	+$2.45M	2.35%	13

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Private Harbour Investment Management & Counsel's AZN Position: Q2 2022 in Review

Private Harbour Investment Management & Counsel sold out of AstraZeneca (AZN) in Q2 2022, closing a stake of 19,372 shares — an estimated $2.57M sold.

Private Harbour Investment Management & Counsel first reported a position in AZN in Q2 2021 and held it in 4 quarters. The position peaked at $2.67M in Q2 2021. 1,016 funds tracked by Wall St. Rank hold AZN as of Q2 2022.

Private Harbour Investment Management & Counsel reported no remaining AstraZeneca position as of Q2 2022 after selling out during the quarter.
Private Harbour Investment Management & Counsel sold 19,372 AstraZeneca shares in Q2 2022, an estimated $2.57M.
Private Harbour Investment Management & Counsel first reported a position in AstraZeneca in Q2 2021 and held it in 4 quarters.
Private Harbour Investment Management & Counsel's AstraZeneca position peaked at $2.67M in Q2 2021.
1,016 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2022.

Based on Private Harbour Investment Management & Counsel's 13F filing for Q2 2022, filed 13 Jul 2022.